Developing cost-efficient wastewater treatment technologies for safe reuse is essential, especially in developing countries simultaneously facing water scarcity. This study developed and evaluated a hybrid constructed wetlands (CWs) approach, incorporating tidal flow (TF) operation and utilising local Jordanian zeolite as a wetland substrate for real pharmaceutical industry wastewater treatment. Over 273 days of continuous monitoring, the results revealed that the first-stage TFCWs filled with either raw or modified zeolite performed significantly higher reductions in Chemical Oxygen Demand (COD, 58 %–60 %), Total Nitrogen (TN, 32 %–37 %), and Phosphate (PO4, 46 %–64 %) compared to TFCWs filled with normal sand. Water quality further improved after the second stage of horizontal subsurface flow CWs treatment, achieving log removals of 1.09–2.47 for total coliform and 1.89–2.09 for E. coli. With influent pharmaceutical concentrations ranging from 275 to 2000 μg/L, the zeolite-filled hybrid CWs achieved complete removal (>98 %) for ciprofloxacin, ofloxacin, erythromycin, and enrofloxacin, moderate removal (43 %–81 %) for flumequine and lincomycin, and limited removal (<8 %) for carbamazepine and diclofenac. The overall accumulation of pharmaceuticals in plant tissue and substrate adsorption accounted for only 2.3 % and 4.3 %, respectively, of the total mass removal. Biodegradation of these pharmaceuticals (up to 61 %) through microbial-mediated processes or within plant tissues was identified as the key removal pathway. For both conventional pollutants and pharmaceuticals, modified zeolite wetland media could only slightly enhance treatment without a significant difference between the two treatment groups. The final effluent from all hybrid CWs complied with Jordanian treated industry wastewater reuse standards (category III), and systems filled with raw or modified zeolite achieved over 95 % of samples meeting the highest water reuse category I. This study provides evidence of using hybrid CWs technology as a nature-based solution to address water safety and scarcity challenges.
This is the first study of its kind in Jordan to develop and evaluate the effectiveness of a hybrid CWs strategy as a nature-based solution for treating real pharmaceutical industry wastewater. Three groups of mesocosm-scale hybrid CWs, consisting of tidal flow CWs and saturated horizontal subsurface flow CWs, were established. Modified and raw local zeolite were used as substrates for comparison with normal sand filled CWs in terms of pharmaceutical removal. The contributions of plant uptake, substrate adsorption, and biodegradation in pharmaceutical removal were assessed in all systems to explore removal pathways. Furthermore, the removal of pathogens (total coliforms and E. coli) was monitored to assess the effluent’s compliance with regulations for treated industrial wastewater reuse. The results of this study could provide valuable evidence supporting the application of nature-based solutions for the effective treatment of pharmaceutical wastewater.
